Sept. 29–30, 2021 • San Diego
View Schedule (coming soon) • Registration Rates (coming soon)
The Society for Immunotherapy of Cancer (SITC) invites you to attend the workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting. Scheduled for Sept. 29–30, 2021, in San Diego, this SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. By bringing together experts on the topic from a variety of fields including medical oncology, bioinformatics, cancer biology, genetics/epigenetics, immunology, and many others, the workshop will facilitate increased discussion in this important area.
Concepts ranging from the basic biology of cancer cell surface molecules to applications of drugs and cellular therapies targeting novel surface markers will be discussed, with the goal of defining the future direction of the field. It is anticipated that the efforts of this workshop will fuel innovative collaborations, disseminate important knowledge to the rest of the immunotherapy field, and help assure the continued growth of immunotherapy treatments as a whole.
Four slots for oral abstract presentations are available during this workshop.
Posters will be presented during the Poster Reception. Poster specifications will be based on the number of abstracts that will be presented and will be provided with acceptance notifications. The presenting author is responsible for printing, bringing and hanging up their poster. SITC does not provide printing services on-site, or special accommodations for disposing of or shipping posters after the workshop.
For more information on abstract guidelines and policies, please click here.
Immediately following the Surfaceome Workshop, SITC is hosting a unique workshop, Bispecific T cell Engagers Workshop, focused on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, impact of the tumor microenvironment, and advances in conditionally-active binding.A collaborative session, taking place the morning of Sept. 30, will allow attendees from both workshops to discuss alignment and debates in the areas of the two workshops with the focus on how to continue to advance the field.It is anticipated that the efforts of these workshops will fuel innovative collaborations, disseminate important knowledge to the rest of the immunotherapy field, and help assure the continued growth of immunotherapy treatments as a whole.Participants will receive a discount when registering for both the BiTEs and Surfaceome workshops, which take place at the same location.
Details coming soon!
Bispecific T cell Engagers Workshop
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org